Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 416

1.

Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors.

Lohmann CM, Coit DG, Brady MS, Berwick M, Busam KJ.

Am J Surg Pathol. 2002 Jan;26(1):47-55.

PMID:
11756768
2.

Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients.

Su LD, Fullen DR, Sondak VK, Johnson TM, Lowe L.

Cancer. 2003 Jan 15;97(2):499-507.

3.

Sentinel lymph node biopsy for patients with diagnostically controversial Spitzoid melanocytic tumors?

Busam KJ, Pulitzer M.

Adv Anat Pathol. 2008 Sep;15(5):253-62. doi: 10.1097/PAP.0b013e31818323ac. Review.

PMID:
18724099
4.

Sentinel lymph node biopsy for atypical melanocytic lesions with spitzoid features.

Gamblin TC, Edington H, Kirkwood JM, Rao UN.

Ann Surg Oncol. 2006 Dec;13(12):1664-70.

PMID:
17024556
5.

Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors).

Murali R, Sharma RN, Thompson JF, Stretch JR, Lee CS, McCarthy SW, Scolyer RA.

Ann Surg Oncol. 2008 Jan;15(1):302-9. Epub 2007 Nov 14.

PMID:
18000712
6.

The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution.

Ludgate MW, Fullen DR, Lee J, Lowe L, Bradford C, Geiger J, Schwartz J, Johnson TM.

Cancer. 2009 Feb 1;115(3):631-41. doi: 10.1002/cncr.24047.

7.

Sentinel lymph node biopsy in patients with "atypical Spitz tumors." A report on 12 cases.

Urso C, Borgognoni L, Saieva C, Ferrara G, Tinacci G, Begliomini B, Reali UM.

Hum Pathol. 2006 Jul;37(7):816-23. Epub 2006 May 19.

PMID:
16784980
8.

Spitz nevus and atypical spitzoid neoplasm.

Miteva M, Lazova R.

Semin Cutan Med Surg. 2010 Sep;29(3):165-73. doi: 10.1016/j.sder.2010.06.003. Review.

PMID:
21051010
9.

The dermal-based borderline melanocytic tumor: a categorical approach.

Magro CM, Crowson AN, Mihm MC Jr, Gupta K, Walker MJ, Solomon G.

J Am Acad Dermatol. 2010 Mar;62(3):469-79. doi: 10.1016/j.jaad.2009.06.042.

PMID:
20159313
10.

Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome.

Barnhill RL, Argenyi ZB, From L, Glass LF, Maize JC, Mihm MC Jr, Rabkin MS, Ronan SG, White WL, Piepkorn M.

Hum Pathol. 1999 May;30(5):513-20.

PMID:
10333219
11.

Atypical spitzoid melanocytic tumors with positive sentinel lymph nodes in children and teenagers, and comparison with histologically unambiguous and lethal melanomas.

Busam KJ, Murali R, Pulitzer M, McCarthy SW, Thompson JF, Shaw HM, Brady MS, Coit DG, Dusza S, Wilmott J, Kayton M, Laquaglia M, Scolyer RA.

Am J Surg Pathol. 2009 Sep;33(9):1386-95. doi: 10.1097/PAS.0b013e3181ac1927.

PMID:
19609204
12.

The role of sentinel node biopsy in the management of melanocytic lesions of uncertain malignant potential (MUMP).

McArthur GJ, Banwell ME, Cook MG, Powell BW.

J Plast Reconstr Aesthet Surg. 2007;60(8):952-4. Epub 2006 Jun 27.

PMID:
17616368
13.

Utility of lymph node assessment for atypical spitzoid melanocytic neoplasms.

Ghazi B, Carlson GW, Murray DR, Gow KW, Page A, Durham M, Kooby DA, Parker D, Rapkin L, Lawson DH, Delman KA.

Ann Surg Oncol. 2010 Sep;17(9):2471-5. doi: 10.1245/s10434-010-1022-3. Epub 2010 Mar 12.

PMID:
20224858
14.

Sentinel lymph node biopsy for melanoma and other melanocytic tumors in adolescents.

Roaten JB, Partrick DA, Pearlman N, Gonzalez RJ, Gonzalez R, McCarter MD.

J Pediatr Surg. 2005 Jan;40(1):232-5.

PMID:
15868590
15.

[Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].

Keijzer R, Bril H, van der Loo EM, de Graaf PW.

Ned Tijdschr Geneeskd. 2004 May 1;148(18):884-8. Dutch.

PMID:
15152391
16.

Survival in sentinel lymph node-positive pediatric melanoma.

Roaten JB, Partrick DA, Bensard D, Pearlman N, Gonzalez R, Fitzpatrick J, McCarter MD.

J Pediatr Surg. 2005 Jun;40(6):988-92; discussion 992.

PMID:
15991183
17.

Sentinel lymph node metastasis is not predictive of poor outcome in patients with problematic spitzoid melanocytic tumors.

Hung T, Piris A, Lobo A, Mihm MC Jr, Sober AJ, Tsao H, Tanabe KK, Duncan LM.

Hum Pathol. 2013 Jan;44(1):87-94. doi: 10.1016/j.humpath.2012.04.019. Epub 2012 Aug 30.

PMID:
22939951
18.

Spitzoid melanoma.

Kamino H.

Clin Dermatol. 2009 Nov-Dec;27(6):545-55. doi: 10.1016/j.clindermatol.2008.09.013. Review.

PMID:
19880042
19.

Histologically ambiguous ("borderline") primary cutaneous melanocytic tumors: approaches to patient management including the roles of molecular testing and sentinel lymph node biopsy.

Scolyer RA, Murali R, McCarthy SW, Thompson JF.

Arch Pathol Lab Med. 2010 Dec;134(12):1770-7. doi: 10.1043/2009-0612-RAR.1. Review.

PMID:
21128774
20.

Non-sentinel lymph node involvement in a patient with an atypical Spitz tumor and a positive sentinel node. Report of a case and review of the literature.

Urso C, Borgognoni L, Doria M, Tinacci G, Zini E.

J Cutan Pathol. 2009 May;36(5):586-90. doi: 10.1111/j.1600-0560.2008.01080.x. Epub 2009 Mar 30. Review.

PMID:
19476530

Supplemental Content

Support Center